Ratna Dwi Ramadani

Arylamide as Potential Selective Inhibitor for Matrix Metalloproteinase 9 (MMP9): Design, Synthesis, Biological Evaluation, and Molecular Modeling

Muhammad Yusuf, Maywan Hariono, Rina Fajri Nuwarda, 2019, J. Chem. Inf. Model..

Glycoengineering of Darbepoetin-α in CHO-DG44 Cells through Overexpression of α-2,3-sialyl-transferase and CMP-sialic Acid Transporter

Ratna Dwi Ramadani, P. H. Wisnuwardhani, A. Santoso, 2022, HAYATI Journal of Biosciences.

Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells

Ratna Dwi Ramadani, Rohmad Yudi Utomo, E. Meiyanto, 2019, Investigational New Drugs.

Curcumin Analog Pentagamaboronon-0-Sorbitol Inhibits Cell Migration Activity of Triple Negative Breast Cancer Cell Line

Ratna Dwi Ramadani, Rohmad Yudi Utomo, E. Meiyanto, 2018, Indonesian Journal of Cancer Chemoprevention.

Expression of receptor binding domain spike of SARS CoV-2 as a fusion protein in CHOK-1 cell line

Ratna Dwi Ramadani, R. A. Ningrum, P. H. Wisnuwardhani, 2023, AIP Conference Proceedings.

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application

Ratna Dwi Ramadani, Rohmad Yudi Utomo, E. Meiyanto, 2019, Research in pharmaceutical sciences.